|
Protein Design Labs is a fully-integrated biopharmaceutical
company focused on the development and commercialization of
novel therapies for treatment of inflammation and autoimmune
diseases, acute cardiac conditions and cancer. As a leader
in the development of humanized antibodies, PDL has licensed
its patents to numerous pharmaceutical and biotechnology companies,
some of which are now paying royalties on net sales of licensed
products. PDL markets several pharmaceutical products in the
United States through its wholly-owned subsidiary, ESP Pharma,
Inc. Further information on PDL is available at www.pdl.com
or by contacting James R. Goff, Senior Director, PDL Corporate
Communications, (510) 574-1421 or jgoff@pdl.com.
Protein Design Labs and the PDL logo are registered U.S. trademarks
of Protein Design Labs, Inc.
|
|
BayHelix is a business-focused non-profit organization
for Chinese life sciences leaders. The organization has over
150 members distributed across United States, Canada and China.
BayHelix members include corporate executives, entrepreneurs,
venture capitalists, management consultants, investment bankers,
lawyers, and other high caliber individuals in life sciences-related
areas. The membership is by invitation only. For more detailed
info please visit website: www.bayhelix.org
|
Home